EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology.
Read More…
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Phone33-04-72-15-31-50
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$46.17 million
Profitability
Miscellaneous
Employees215
Next Earnings Date11/13/2019 (Estimated)
OptionableOptionable
Edap Tms (NASDAQ:EDAP) Frequently Asked Questions
What is Edap Tms' stock symbol?
Edap Tms trades on the NASDAQ under the ticker symbol "EDAP."
How were Edap Tms' earnings last quarter?
Edap Tms SA (NASDAQ:EDAP) announced its quarterly earnings results on Wednesday, August, 28th. The medical equipment provider reported $0.05 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.01 by $0.04. The medical equipment provider earned $14.04 million during the quarter, compared to the consensus estimate of $11.92 million. Edap Tms had a net margin of 4.57% and a return on equity of 23.31%. View Edap Tms' Earnings History.
When is Edap Tms' next earnings date?
What price target have analysts set for EDAP?
1 equities research analysts have issued twelve-month target prices for Edap Tms' stock. Their forecasts range from $7.00 to $7.00. On average, they anticipate Edap Tms' share price to reach $7.00 in the next year. This suggests a possible upside of 48.9% from the stock's current price. View Analyst Price Targets for Edap Tms.
What is the consensus analysts' recommendation for Edap Tms?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Edap Tms.
Has Edap Tms been receiving favorable news coverage?
Press coverage about EDAP stock has trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Edap Tms earned a coverage optimism score of -1.2 on InfoTrie's scale. They also assigned press coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Edap Tms.
Are investors shorting Edap Tms?
Edap Tms saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 51,900 shares, an increase of 30.1% from the August 30th total of 39,900 shares. Based on an average daily trading volume, of 191,400 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.2% of the company's shares are sold short. View Edap Tms' Current Options Chain.
Who are some of Edap Tms' key competitors?
Some companies that are related to Edap Tms include AxoGen (AXGN), Cutera (CUTR), Zynex (ZYXI), TransMedics Group (TMDX), BioLife Solutions (BLFS), Semler Scientific (SMLR), Viewray (VRAY), Stereotaxis (STXS), BioSig Technologies (BSGM), Rockwell Medical (RMTI), Fonar (FONR), Second Sight Medical Products (EYES), Fc Global Realty (FCRE), electroCore (ECOR) and Soleno Therapeutics (SLNO).
What other stocks do shareholders of Edap Tms own?
Who are Edap Tms' key executives?
Edap Tms' management team includes the folowing people:
- Mr. Marc Oczachowski, CEO & Exec. Director (Age 49)
- Mr. Franois Dietsch, Chief Financial Officer (Age 43)
- Ms. Blandine Confort, Investor Relations Officer and Sec.
How do I buy shares of Edap Tms?
Shares of EDAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Edap Tms' stock price today?
One share of EDAP stock can currently be purchased for approximately $4.70.
How big of a company is Edap Tms?
Edap Tms has a market capitalization of $136.29 million and generates $46.17 million in revenue each year. The medical equipment provider earns $-400,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Edap Tms employs 215 workers across the globe.View Additional Information About Edap Tms.
What is Edap Tms' official website?
How can I contact Edap Tms?
Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The medical equipment provider can be reached via phone at 33-04-72-15-31-50 or via email at [email protected]
MarketBeat Community Rating for Edap Tms (NASDAQ EDAP)
MarketBeat's community ratings are surveys of what our community members think about Edap Tms and other stocks. Vote "Outperform" if you believe EDAP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EDAP will underperform the S&P 500 over the long term. You may vote once every thirty days.
